Sysmex Corporation (SSMXY.PK) and QIAGEN K.K., the Japanese subsidiary of QIAGEN N.V., announced on Wednesday that they have entered into a partnership for clinical diagnostic products in molecular diagnostics.
The agreement builds on the collaboration the companies established last year in clinical diagnostics. Under the partnership, Sysmex and QIAGEN will distribute QIAGEN's clinical diagnostic instruments, reagents, and other products for infectious diseases and cancer in Japan, and introduce them to hospitals and testing centers.
The collaboration will begin with existing clinical testing products, including cancer molecular diagnostics and tuberculosis testing using the QuantiFERON-TB Gold Plus test, with plans to expand the product lineup in Japan over time.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.